Here’s What You Receive:
FDA Authorized antibody test for COVID-19
Same or Next-day results from a CLIA approved lab
The opportunity for confirmatory testing through PCR analysis
Our serological test identifies the presence of antibodies indicating an individual has or had an immune response to the SARS-CoV-2 virus (also known as COVID-19 or coronavirus). As of May 7, 2020, the test utilized by Vanguard Genetics is one of only 12 tests authorized by the FDA under Emergency Use Authorization and is available without the need for a prescription or health insurance.
This test identifies the presence of both IgM and IgG antibodies and as a result, can be used as an indicator of both past and present infection. However, this test is not to be used for sole diagnosis of an active infection. An indication of active infection should be followed up with a PCR screening, which is the “gold standard” for active infection screening.
Antibody testing is generally for people who are not currently experiencing symptoms related to COVID-19. Current data indicates it may take up to 14 days after the onset of symptoms for antibodies to be developed within the body. However, 91% of individuals develop antibodies within the first 8-13 days.